New collaboration could transform neonatal therapy
With no currently approved medicines for the prevention of bronchopulmonary…
With no currently approved medicines for the prevention of bronchopulmonary dysplasia (BPD) in extremely pre-term infants, a new pharmaceutical collaboration could produce the first major therapeutic breakthrough for this patient group in decades.